Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Special Features of Adaptive Immunity01:20

Special Features of Adaptive Immunity

1.1K
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
1.1K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

4.2K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
4.2K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

71.5K
Overview
71.5K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

1.7K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.7K
T Cell Types and Functions01:24

T Cell Types and Functions

1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
Diversity of Antigen Receptors01:28

Diversity of Antigen Receptors

774
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
774

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unconventional activation of the proto-oncogene FGFR1 by extracellular phosphate via H<sub>2</sub>O<sub>2</sub>-mediated kinase oxidation.

Cell reports·2026
Same author

isMap - immunological synapse map analysis program.

Frontiers in immunology·2026
Same author

Lysosomal membrane homeostasis and its importance in physiology and disease.

Nature reviews. Molecular cell biology·2025
Same author

Phosphoinositides as regulators of membrane contact sites.

Biochimica et biophysica acta. Molecular and cell biology of lipids·2025
Same author

The expanding repertoire of ESCRT functions in cell biology and disease.

Nature·2025
Same author

Sustained release of cytokines from migrasomes.

Extracellular vesicles and circulating nucleic acids·2025
Same journal

Adenosine as a metabolic checkpoint in CD8+ T cell dysfunction.

Trends in immunology·2026
Same journal

IL-33 scripts cancer immunity.

Trends in immunology·2026
Same journal

Mitochondrial Ca<sup>2+</sup> signaling: A metabolic rheostat defining tumor and immune cell fate.

Trends in immunology·2026
Same journal

Cross-priming underlies the efficacy of antibody-drug conjugates and immunotherapy combinations.

Trends in immunology·2026
Same journal

Gut microbiome metabolites meet immunometabolism in inflammatory bowel disease.

Trends in immunology·2026
Same journal

Metabolic regulatory nodes of the inflammasome and inflammatory cell death.

Trends in immunology·2026
See all related articles

Related Experiment Video

Updated: Sep 5, 2025

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice
07:17

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice

Published on: June 22, 2016

9.9K

ESCRTed resistance to T cell attack.

Simona Maria Migliano1, Harald Stenmark2

  • 1Centre for Cancer Cell Reprogramming, Faculty of Medicine, University of Oslo, Montebello, N-0379 Oslo, Norway; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, N-0379 Oslo, Norway.

Trends in Immunology
|July 9, 2022
PubMed
Summary
This summary is machine-generated.

Cancer cells can actively remove pores created by cytotoxic T lymphocytes (CTLs) using endosomal sorting complex required for transport (ESCRT) proteins. This mechanism helps cancer cells evade CTL-mediated killing, impacting cancer immunotherapy.

More Related Videos

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

6.8K
Isolation and Th17 Differentiation of Na&#239;ve CD4 T Lymphocytes
12:59

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes

Published on: September 26, 2013

34.7K

Related Experiment Videos

Last Updated: Sep 5, 2025

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice
07:17

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice

Published on: June 22, 2016

9.9K
Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

6.8K
Isolation and Th17 Differentiation of Na&#239;ve CD4 T Lymphocytes
12:59

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes

Published on: September 26, 2013

34.7K

Area of Science:

  • Immunology
  • Cell Biology
  • Cancer Research

Background:

  • Cytotoxic T cells are crucial for eliminating cancer cells.
  • These immune cells induce cancer cell death by forming pores in their plasma membrane.
  • Toxic enzymes are then secreted through these pores to kill the target cell.

Purpose of the Study:

  • To investigate the mechanisms by which cancer cells survive cytotoxic T cell attacks.
  • To identify cellular processes that counteract T cell-mediated cytotoxicity.

Main Methods:

  • Utilized advanced microscopy and molecular biology techniques.
  • Investigated the role of endosomal sorting complex required for transport (ESCRT) proteins in cancer cells.
  • Assessed the impact of ESCRT on pore removal and T cell killing.

Main Results:

  • Demonstrated that cancer cells actively remove cytotoxic T cell-induced pores.
  • Identified ESCRT proteins as key mediators of this pore removal process.
  • Showed that ESCRT-mediated pore clearance effectively counteracts CD8+ T cell killing.

Conclusions:

  • Cancer cells possess a defense mechanism against cytotoxic T cells involving ESCRT.
  • Targeting ESCRT could potentially enhance the efficacy of T cell-based cancer immunotherapies.
  • Understanding this interaction is vital for developing new cancer treatment strategies.